Market Overview:
The global hepatitis B virus core antibody diagnostic kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of hepatitis B, rising awareness about available diagnostic tests, and technological advancements in the field of diagnostics. Based on type, the global hepatitis B virus core antibody diagnostic kits market can be segmented into 48T kits and 96T kits. The 96T kit segment is expected to grow at a higher CAGR than the 48T kit segment during the forecast period from 2018 to 2030. This growth can be attributed to increased demand for high-throughput tests for diagnosis of hepatitis B infection. Based on application, the global hepatitis B virus core antibody diagnostic kits market can be divided into three segments: hepatic clinical testing, hepatic efficacy surveillance, and other applications. The hepatic clinical testing segment is expected to account for a major share of this market in 2018 owing to increasing use of these tests for diagnosis and treatment decisions related to various forms of liver diseases including viral infections such as hepatitis A &B and non-viral infections such as alcoholic liver disease (ALD) & fatty liver disease (FLD).
Product Definition:
Hepatitis B virus (HBV) core antibody diagnostic kits are used to detect the presence of antibodies against the HBV core antigen in serum or plasma. The presence of these antibodies indicates that a person has been infected with HBV and may be at risk for developing chronic hepatitis, cirrhosis, or liver cancer.
48T Kits:
48T kits are used for the detection of hepatitis B core antibody in patient's serum or plasma. It is also used as a diagnostic tool to detect the presence of other viruses like Hepatitis A Virus, Liver Fluke Virus, and others. The major factor driving this market is growing demand for rapid diagnostic tests that can identify chronic viral infections such as HIV/AIDS and HBV due to increasing prevalence rates globally.
96T Kits:
96T kits are used in the detection of hepatitis B virus core antibody. It is a type of immunoassay that uses 96 wells plate to make several tests simultaneously. The major advantage associated with this test is that it can detect antibodies from any patient who has been infected with HBV and has produced anti-HBc Ab, regardless of the time since infection. This test also helps in monitoring response to antiviral drugs as well as determining if patient needs liver transplantation or not.
Application Insights:
Based on application, the global hepatitis B virus core antibody diagnostic kits market is segmented into hepatitis B clinical testing, efficacy surveillance, other applications. The efficacy surveillance segment held the largest share in 2017 and is anticipated to maintain its dominance over the forecast period. This can be attributed to a rise in prevalence of chronic HBV infection coupled with high demand for effective diagnosis of HBV infection at an early stage.
The introduction of novel diagnostic technologies such as real-time PCR has led to significant reduction in cost and turnaround time for detection of viral genome from blood samples thereby contributing towards growth of this segment. Furthermore, introduction of these tests by manufacturers along with product updates pertaining to FDA approval has further propelled growth within this segment during recent years.
Regional Analysis:
North America dominated the global hepatitis B virus core antibody diagnostic kits market in 2017. This can be attributed to the presence of a favorable reimbursement framework, high healthcare expenditure, and increasing prevalence of chronic diseases. The U.S., which is at the forefront of this region, accounted for approximately 80% share in North America owing to its well-developed healthcare infrastructure and advanced diagnostic techniques coupled with rising awareness about these tests among people living with chronic infections such as HIV/AIDS or HCV infection.
Asia Pacific is expected to witness lucrative growth over the forecast period due to an increase in demand for cost-effective & faster diagnostics that are not affected by temperature changes or humidity levels along with a rise in prevalence of hepatitis B virus infection across countries such as India & China and other developing economies including Indonesia & Malaysia etc.; hence boosting revenue generation from 2016 to 2030 in this region.
Growth Factors:
- Increasing incidence of hepatitis B virus infection
- Growing awareness about the benefits of early diagnosis and treatment of hepatitis B virus infection
- Rising demand for point-of-care diagnostics kits
- Technological advancements in diagnostic kits for hepatitis B virus core antibody detection
- Growing number of public and private sector initiatives to promote early diagnosis and treatment of hepatitis B virus infection
Scope Of The Report
Report Attributes
Report Details
Report Title
Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report
By Type
48T Kits, 96T Kits
By Application
Hepatitis B Clinical Testing, Hepatitis B Efficacy Surveillance, Other
By Companies
Shanghai Kehua Bio, Livzon Pharmaceutical Group, Weihai Weigao Biotechnology, Rongsheng, Wantai Biophram, Asintec, Acon, Shenzhen Kang Sheng Bao Bio-Technology, Autobio, Beijing Kewei Clinical Diagnostic Peagents, Henan Lili Biological Engineering, Zhongshan Bio-tech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Report Segments:
The global Hepatitis B Virus Core Antibody Diagnostic Kits market is segmented on the basis of:
Types
48T Kits, 96T Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hepatitis B Clinical Testing, Hepatitis B Efficacy Surveillance, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shanghai Kehua Bio
- Livzon Pharmaceutical Group
- Weihai Weigao Biotechnology
- Rongsheng
- Wantai Biophram
- Asintec
- Acon
- Shenzhen Kang Sheng Bao Bio-Technology
- Autobio
- Beijing Kewei Clinical Diagnostic Peagents
- Henan Lili Biological Engineering
- Zhongshan Bio-tech
Highlights of The Hepatitis B Virus Core Antibody Diagnostic Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 48T Kits
- 96T Kits
- By Application:
- Hepatitis B Clinical Testing
- Hepatitis B Efficacy Surveillance
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hepatitis B Virus Core Antibody Diagnostic Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hepatitis B Virus Core Antibody Diagnostic Kits are a type of laboratory test that is used to determine if someone has been infected with the hepatitis B virus. This test is used to confirm the presence of the virus in a person's blood and can also help identify any signs or symptoms of infection.
Some of the key players operating in the hepatitis b virus core antibody diagnostic kits market are Shanghai Kehua Bio, Livzon Pharmaceutical Group, Weihai Weigao Biotechnology, Rongsheng, Wantai Biophram, Asintec, Acon, Shenzhen Kang Sheng Bao Bio-Technology, Autobio, Beijing Kewei Clinical Diagnostic Peagents, Henan Lili Biological Engineering, Zhongshan Bio-tech.
The hepatitis b virus core antibody diagnostic kits market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hepatitis B Virus Core Antibody Diagnostic Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hepatitis B Virus Core Antibody Diagnostic Kits Market - Supply Chain
4.5. Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Forecast
4.5.1. Hepatitis B Virus Core Antibody Diagnostic Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hepatitis B Virus Core Antibody Diagnostic Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market Absolute $ Opportunity
5. Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Type
5.3.1. 48T Kits
5.3.2. 96T Kits
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Application
6.3.1. Hepatitis B Clinical Testing
6.3.2. Hepatitis B Efficacy Surveillance
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hepatitis B Virus Core Antibody Diagnostic Kits Demand Share Forecast, 2019-2026
9. North America Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Application
9.4.1. Hepatitis B Clinical Testing
9.4.2. Hepatitis B Efficacy Surveillance
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Type
9.7.1. 48T Kits
9.7.2. 96T Kits
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hepatitis B Virus Core Antibody Diagnostic Kits Demand Share Forecast, 2019-2026
10. Latin America Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Application
10.4.1. Hepatitis B Clinical Testing
10.4.2. Hepatitis B Efficacy Surveillance
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Type
10.7.1. 48T Kits
10.7.2. 96T Kits
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hepatitis B Virus Core Antibody Diagnostic Kits Demand Share Forecast, 2019-2026
11. Europe Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Application
11.4.1. Hepatitis B Clinical Testing
11.4.2. Hepatitis B Efficacy Surveillance
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hepatitis B Virus Core Antibody Diagnostic Kits MarketSize and Volume Forecast by Type
11.7.1. 48T Kits
11.7.2. 96T Kits
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hepatitis B Virus Core Antibody Diagnostic Kits Demand Share, 2019-2026
12. Asia Pacific Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Application
12.4.1. Hepatitis B Clinical Testing
12.4.2. Hepatitis B Efficacy Surveillance
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Type
12.7.1. 48T Kits
12.7.2. 96T Kits
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hepatitis B Virus Core Antibody Diagnostic Kits Demand Share, 2019-2026
13. Middle East & Africa Hepatitis B Virus Core Antibody Diagnostic Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Application
13.4.1. Hepatitis B Clinical Testing
13.4.2. Hepatitis B Efficacy Surveillance
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hepatitis B Virus Core Antibody Diagnostic Kits Market Size and Volume Forecast by Type
13.7.1. 48T Kits
13.7.2. 96T Kits
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hepatitis B Virus Core Antibody Diagnostic Kits Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hepatitis B Virus Core Antibody Diagnostic Kits Market: Market Share Analysis
14.2. Hepatitis B Virus Core Antibody Diagnostic Kits Distributors and Customers
14.3. Hepatitis B Virus Core Antibody Diagnostic Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shanghai Kehua Bio
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Livzon Pharmaceutical Group
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Weihai Weigao Biotechnology
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Rongsheng
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Wantai Biophram
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Asintec
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Acon
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Shenzhen Kang Sheng Bao Bio-Technology
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Autobio
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Beijing Kewei Clinical Diagnostic Peagents
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Henan Lili Biological Engineering
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Zhongshan Bio-tech
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook